Abeona Therapeutics ABEO
NASDAQ ABEO
$2.60 +0.18 (+7.44%)
At close: Nov 16, 2026 · 4:00 PM EST

Abeona Therapeutics (ABEO) Current Deferred Tax Assets (2009 - 2010)

Updated

Abeona Therapeutics (ABEO) posted Current Deferred Tax Assets of -$75.61 million for Q4 2010, compared with -$72.51 million a year earlier.

Analysis

Abeona Therapeutics (ABEO) Current Deferred Tax Assets (2009 - 2010) Analysis & Trends

  • In prior years, Abeona Therapeutics' Current Deferred Tax Assets was -$72.51 million in FY2009.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn
5 Novartis Ag 310.90 Bn 284.14 Bn -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn
10 Abeona Therapeutics 149.28 Mn -492.16 Mn 7.78 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2010 -75.61 Mn
Dec 31, 2009 -72.51 Mn
API Access

Abeona Therapeutics Current Deferred Tax Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-tax-assets&ticker=ABEO&period=max&api_key=YOUR_API_KEY